Medical - Distribution industry analysis: EL7 Score and the best stocks ranked by value, profitability, and momentum.
Ranked among 5 stocks with a market cap above $500M. Smaller companies are excluded from the ranking.
Rank | Company | Price | P/E | Value | Growth | Quality | EL7 Score |
|---|---|---|---|---|---|---|---|
| 1/5 | ![]() | $992.87 | 26.6 | 24 | 52 | 60 | 90 |
| 2/5 | ![]() | $251.54 | 34.8 | 33 | 90 | 80 | 81 |
| 3/5 | ![]() | $84.51 | 24.6 | 52 | 14 | 30 | 67 |
| 4/5 | ![]() | $330.00 | 24.5 | 48 | 48 | 65 | 52 |
| 5/5 | ![]() | $1.27 | 19.2 | 38 | 43 | 85 | 19 |
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
17 of 152
P/E 24.6 vs period average 24.1 Near its historical average
Score = market-cap-weighted percentile rank of the sector stocks vs the whole market (0-100). Higher = stronger.
Funds that track the sector and each fund's exposure to it.
Fund | Exposure | Assets | Expense |
|---|---|---|---|
| IBBiShares Biotechnology ETF | 100.0% | $11B | 0.44% |
| VHTVanguard Health Care ETF | 100.0% | $22B | 0.09% |
| IHIiShares U.S. Medical Devices ETF | 99.7% | $4B | 0.37% |
| XLVState Street Health Care Select Sector SPDR ETF | 99.1% | $48B | 0.08% |
The percentage is the sector's share of the fund's assets, per the latest available data.
Upgrades and downgrades on the sector's stocks